Compumedics Financial Debt Ratio
The Financial Debt Ratio of Compumedics (CMP.AX) as of Sep 2, 2026 is 25.54 %. In the previous year, Financial Debt Ratio was 21.25 % — a change of 20.16% (higher).
Get this data via API
Financial Data API
Financial Debt Ratio
25.54 %
YoY
20.16%
Last updated:
The Compumedics Financial Debt Ratio history
3 Years
10 Years
25 Years
Max
| YEAR | Financial Debt Ratio | YoY |
|---|---|---|
| 25.54 % | +20.16% | |
| 21.25 % | -7.53% | |
| 22.99 % | +46.41% | |
| 15.70 % | +3.98% | |
| 15.10 % | +11.78% | |
| 13.51 % | +227.83% | |
| 4.12 % | -24.49% | |
| 5.46 % | +123.08% | |
| 2.45 % | -75.20% | |
| 9.86 % | +6.80% | |
| 9.24 % | -10.74% | |
| 10.35 % | — |
Compumedics Stock analysis
Frequently Asked Questions about Compumedics stock
Financial Debt Ratio of Compumedics is 25.54 % in 2026.
Financial Debt Ratio of Compumedics changed from 21.25 % to 25.54 %, representing a 20.16% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Financial Debt Ratio Compumedics since 2006 – with annual values, charts, and detailed analysis.
The financial debt ratio measures interest-bearing financial debt as a percentage of total assets. It isolates funded debt from trade and other non-financial obligations.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Debt Ratio's Compumedics with sector peers and the industry average to assess whether it is attractive.
Leverage — Compumedics
All Key Metrics — Compumedics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth